Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens / Fiona M. Behan, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M. Beaver, Giorgia Migliardi, Rita Santos, Yanhua Rao, Francesco Sassi, Marika Pinnelli, Rizwan Ansari, Sarah Harper, David Adam Jackson, Rebecca McRae, Rachel Pooley, Piers Wilkinson, Dieudonne van der Meer, David Dow, Carolyn Buser-Doepner, Andrea Bertotti, Livio Trusolino, Euan A. Stronach, Julio Saez-Rodriguez, Kosuke Yusa & Mathew J. Garnett
In a screen of 324 human cancer cell lines and utilising a systematic target prioritization framework, the Werner syndrome ATP-dependent helicase is shown to be a synthetic lethal target in tumours from multiple cancer types with microsatellite instability, providing a new target for cancer drug development..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
10 April 2019 2019 |
---|---|
Erschienen: |
10 April 2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:568 |
---|---|
Enthalten in: |
Nature |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Behan, Fiona M. [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Gesehen am 24.09.2019 |
---|
Umfang: |
6 |
---|
doi: |
10.1038/s41586-019-1103-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1677583517 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1677583517 | ||
003 | DE-627 | ||
005 | 20230427002400.0 | ||
007 | cr uuu---uuuuu | ||
008 | 190924s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41586-019-1103-9 |2 doi | |
035 | |a (DE-627)1677583517 | ||
035 | |a (DE-599)KXP1677583517 | ||
035 | |a (OCoLC)1341244516 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Behan, Fiona M. |e verfasserin |0 (DE-588)1195555652 |0 (DE-627)1677584718 |4 aut | |
245 | 1 | 0 | |a Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens |c Fiona M. Behan, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M. Beaver, Giorgia Migliardi, Rita Santos, Yanhua Rao, Francesco Sassi, Marika Pinnelli, Rizwan Ansari, Sarah Harper, David Adam Jackson, Rebecca McRae, Rachel Pooley, Piers Wilkinson, Dieudonne van der Meer, David Dow, Carolyn Buser-Doepner, Andrea Bertotti, Livio Trusolino, Euan A. Stronach, Julio Saez-Rodriguez, Kosuke Yusa & Mathew J. Garnett |
264 | 1 | |c 10 April 2019 | |
300 | |a 6 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 24.09.2019 | ||
520 | |a In a screen of 324 human cancer cell lines and utilising a systematic target prioritization framework, the Werner syndrome ATP-dependent helicase is shown to be a synthetic lethal target in tumours from multiple cancer types with microsatellite instability, providing a new target for cancer drug development. | ||
700 | 1 | |a Iorio, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Picco, Gabriele |e verfasserin |4 aut | |
700 | 1 | |a Gonçalves, Emanuel |e verfasserin |4 aut | |
700 | 1 | |a Beaver, Charlotte M. |e verfasserin |4 aut | |
700 | 1 | |a Migliardi, Giorgia |e verfasserin |4 aut | |
700 | 1 | |a Santos, Rita |e verfasserin |4 aut | |
700 | 1 | |a Rao, Yanhua |e verfasserin |4 aut | |
700 | 1 | |a Sassi, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Pinnelli, Marika |e verfasserin |4 aut | |
700 | 1 | |a Ansari, Rizwan |e verfasserin |4 aut | |
700 | 1 | |a Harper, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Jackson, David Adam |e verfasserin |4 aut | |
700 | 1 | |a McRae, Rebecca |e verfasserin |4 aut | |
700 | 1 | |a Pooley, Rachel |e verfasserin |4 aut | |
700 | 1 | |a Wilkinson, Piers |e verfasserin |4 aut | |
700 | 1 | |a Meer, Dieudonne van der |e verfasserin |4 aut | |
700 | 1 | |a Dow, David |e verfasserin |4 aut | |
700 | 1 | |a Buser-Doepner, Carolyn |e verfasserin |4 aut | |
700 | 1 | |a Bertotti, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Trusolino, Livio |e verfasserin |4 aut | |
700 | 1 | |a Stronach, Euan A. |e verfasserin |4 aut | |
700 | 1 | |a Sáez Rodríguez, Julio |d 1978- |e verfasserin |0 (DE-588)133764362 |0 (DE-627)555766632 |0 (DE-576)300083114 |4 aut | |
700 | 1 | |a Yusa, Kosuke |e verfasserin |4 aut | |
700 | 1 | |a Garnett, Mathew J. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature <London> |d London [u.a.] : Nature Publ. Group, 1869 |g 568(2019), 7753, Seite 511-516 |h Online-Ressource |w (DE-627)240151402 |w (DE-600)1413423-8 |w (DE-576)079718426 |x 1476-4687 |7 nnns |
773 | 1 | 8 | |g volume:568 |g year:2019 |g number:7753 |g pages:511-516 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1038/s41586-019-1103-9 |x Verlag |x Resolving-System |3 Volltext |
856 | 4 | 0 | |u https://www.nature.com/articles/s41586-019-1103-9 |x Verlag |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_30 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_211 | ||
912 | |a GBV_ILN_266 | ||
912 | |a GBV_ILN_381 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2037 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2110 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2360 | ||
912 | |a GBV_ILN_2411 | ||
912 | |a GBV_ILN_2522 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4320 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4328 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4700 | ||
936 | u | w | |d 568 |j 2019 |e 7753 |h 511-516 |g 6 |
951 | |a AR | ||
952 | |d 568 |j 2019 |e 7753 |h 511-516 |g 6 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3517697915 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 24-09-19 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2019 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_25 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_6 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1583712178 |a Sáez Rodríguez, Julio | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416734031 |a BIOQUANT | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_23 |